Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report

BACKGROUND: The incidence of gemcitabine-induced hemolytic uremic syndrome has already been described in adults. Several approaches have been employed in the treatment of gemcitabine-induced hemolytic uremic syndrome with different outcomes. One of the most promising agents is eculizumab, which is a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Med Case Rep
Main Authors: Facchini, Ludovica, Lucchesi, Maurizio, Stival, Alessia, Roperto, Rosa Maria, Melosi, Francesca, Materassi, Marco, Farina, Silvia, Tintori, Veronica, de Martino, Maurizio, Sardi, Iacopo
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5530476/
https://ncbi.nlm.nih.gov/pubmed/28747219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-017-1373-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares